Suppr超能文献

表皮生长因子受体酪氨酸激酶调节人内向整流钾通道 K(IR)2.3,该通道稳定表达于 HEK 293 细胞中。

Epidermal growth factor receptor tyrosine kinase regulates the human inward rectifier potassium K(IR)2.3 channel, stably expressed in HEK 293 cells.

机构信息

Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.

出版信息

Br J Pharmacol. 2011 Nov;164(5):1469-78. doi: 10.1111/j.1476-5381.2011.01424.x.

Abstract

BACKGROUND AND PURPOSE

The detailed molecular modulation of inward rectifier potassium channels (including the K(IR) 2.3 channel) is not fully understood. The present study was designed to determine whether human K(IR) 2.3 (K(IR) 2.3) channels were regulated by protein tyrosine kinases (PTKs).

EXPERIMENTAL APPROACH

Whole-cell patch voltage-clamp, immunoprecipitation, Western blot analysis and site-directed mutagenesis were employed to determine the potential PTK phosphorylation of Kir2.3 current in HEK 293 cells stably expressing Kir2.3 gene.

KEY RESULTS

The broad-spectrum PTK inhibitor genistein (10 µM) and the selective epidermal growth factor (EGF) kinase inhibitor AG556 (10 µM) reversibly decreased K(IR) 2.3 current and the effect was reversed by the protein tyrosine phosphatase inhibitor, orthovanadate (1 mM). Although EGF (100 ng·mL(-1) ) and orthovanadate enhanced K(IR) 2.3 current, this effect was antagonized by AG556. However, the Src-family tyrosine kinase inhibitor PP2 (10 µM) did not inhibit K(IR) 2.3 current. Tyrosine phosphorylation of K(IR) 2.3 channels was decreased by genistein or AG556, and was increased by EGF or orthovanadate. The decrease of tyrosine phosphorylation of K(IR) 2.3 channels by genistein or AG556 was reversed by orthovanadate or EGF. Interestingly, the response of K(IR) 2.3 channels to EGF or AG556 was lost in the K(IR) 2.3 Y234A mutant channel.

CONCLUSION AND IMPLICATIONS

These results demonstrate that the EGF receptor tyrosine kinase up-regulates the K(IR) 2.3 channel via phosphorylation of the Y234 residue of the WT protein. This effect may be involved in the endogenous regulation of cellular electrical activity.

摘要

背景与目的

内向整流钾通道(包括 K(IR)2.3 通道)的详细分子调节尚不完全清楚。本研究旨在确定人 K(IR)2.3(K(IR)2.3)通道是否受蛋白酪氨酸激酶(PTKs)调节。

实验方法

采用全细胞片钳电压钳、免疫沉淀、Western blot 分析和定点突变技术,检测稳定表达 Kir2.3 基因的 HEK 293 细胞中 Kir2.3 电流的潜在 PTK 磷酸化。

主要结果

广谱 PTK 抑制剂金雀异黄素(10 μM)和选择性表皮生长因子(EGF)激酶抑制剂 AG556(10 μM)可逆性地降低了 K(IR)2.3 电流,而蛋白酪氨酸磷酸酶抑制剂正钒酸钠(1 mM)则可逆转这一作用。虽然 EGF(100 ng·mL(-1))和正钒酸钠增强了 K(IR)2.3 电流,但这一作用被 AG556 拮抗。然而,Src 家族酪氨酸激酶抑制剂 PP2(10 μM)并不能抑制 K(IR)2.3 电流。金雀异黄素或 AG556 降低 K(IR)2.3 通道的酪氨酸磷酸化,而 EGF 或正钒酸钠则增加其酪氨酸磷酸化。金雀异黄素或 AG556 降低 K(IR)2.3 通道的酪氨酸磷酸化可被正钒酸钠或 EGF 逆转。有趣的是,K(IR)2.3 通道对 EGF 或 AG556 的反应在 K(IR)2.3 Y234A 突变通道中丧失。

结论与意义

这些结果表明,EGF 受体酪氨酸激酶通过 WT 蛋白 Y234 残基的磷酸化而上调 K(IR)2.3 通道。这种作用可能参与了细胞电活动的内源性调节。

相似文献

10
Molecular basis for genistein-induced inhibition of Kir2.3 currents.染料木黄酮诱导抑制Kir2.3电流的分子基础。
Pflugers Arch. 2008 May;456(2):413-23. doi: 10.1007/s00424-007-0391-3. Epub 2007 Dec 18.

引用本文的文献

4
Expression of Septin 2 and Her2/neu in Colorectal Cancer.Septin 2和Her2/neu在结直肠癌中的表达
J Microsc Ultrastruct. 2021 Nov 22;10(4):197-203. doi: 10.4103/jmau.jmau_38_21. eCollection 2022 Oct-Dec.

本文引用的文献

1
Pharmacology of cardiac potassium channels.心脏钾通道药理学。
Adv Pharmacol. 2010;59:93-134. doi: 10.1016/S1054-3589(10)59004-5.
3
Guide to Receptors and Channels (GRAC), 4th Edition.《受体与通道指南》(第4版)
Br J Pharmacol. 2009 Nov;158 Suppl 1(Suppl 1):S1-254. doi: 10.1111/j.1476-5381.2009.00499.x.
6
Molecular basis for genistein-induced inhibition of Kir2.3 currents.染料木黄酮诱导抑制Kir2.3电流的分子基础。
Pflugers Arch. 2008 May;456(2):413-23. doi: 10.1007/s00424-007-0391-3. Epub 2007 Dec 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验